COPD heterogeneity: Gender differences in the multidimensional BODE index
Authors Juan P de Torres, Ciro Casanova, Angela Montejo de Garcini, Armando Aguirre Jaime, Bartolomé R Celli
Published 15 July 2007 Volume 2007:2(2) Pages 151—155
Juan P de Torres1, Ciro Casanova1, Angela Montejo de Garcini1, Armando Aguirre Jaime1, Bartolomé R Celli2
1Respiratory Research Unit, Hospital Universitario Ntra Sra de Candelaria, Tenerife, Spain; 2Pulmonary and Critical Care Division, St Elizabeth´s Caritas Health Care System, Boston, MA, USA
Background: The BODE index was recently validated as a multidimensional tool for the evaluation of patients with COPD. The influence of gender on the BODE index has not been studied.
Hypothesis: The contribution of each component of the disease to the BODE index may differ according to gender.
Methods: We evaluated age, forced expiratory volume in one second (FEV1), Modified Medical Research Council (MMRC) score, 6-min walk distance (6MWD), and body mass index (BMI) in 52 men and 52 women with COPD and the same BODE index. We compared the studied parameters between men and women and then performed a multiple regression analysis by gender.
Results: We found statistically significant differences between men and women in all parameters: FEV1 % (55 ± 17 vs 63 ± 18, p < 0.001), MMRC [1 (0–2) vs 1 (1–2) p = 0.03], BMI [28 (26–30) vs 25 (22–30), p = 0.05], and 6MWD [546 (451–592) vs 462 (419–520), p = 0.001]. Multiple regression analysis revealed that each component of the BODE index had different weight (β standardized coefficient) in men and women respectively: FEV1% (0.74 vs 0.62), MMRC (0.31 vs 0.48), BMI (–0.09 vs –0.17), and 6MWD (0.13 vs 0.10).
Conclusions: The contribution of each component to the BODE index differs by gender in subjects with similar BODE scores. Long term longitudinal studies will help determine the significance of our findings.
Keywords: Gender, COPD, BODE index